GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bakhu Holdings Corp (OTCPK:BKUH) » Definitions » Altman Z2-Score

Bakhu Holdings (Bakhu Holdings) Altman Z2-Score : -226.95 (As of May. 19, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Bakhu Holdings Altman Z2-Score?

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

Bakhu Holdings has a Altman Z2-Score of -226.95, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Bakhu Holdings's Altman Z2-Score or its related term are showing as below:

BKUH' s Altman Z2-Score Range Over the Past 10 Years
Min: -121160.44   Med: -2965.87   Max: -141.13
Current: -226.95

During the past 10 years, Bakhu Holdings's highest Altman Z2-Score was -141.13. The lowest was -121160.44. And the median was -2965.87.


Bakhu Holdings Altman Z2-Score Historical Data

The historical data trend for Bakhu Holdings's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bakhu Holdings Altman Z2-Score Chart

Bakhu Holdings Annual Data
Trend Jul08 Jul09 Jul10 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -60,111.02 -3,067.85 -2,857.50 -394.22 -571.44

Bakhu Holdings Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -570.39 -626.62 -571.44 -433.15 -226.95

Competitive Comparison of Bakhu Holdings's Altman Z2-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Bakhu Holdings's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bakhu Holdings's Altman Z2-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bakhu Holdings's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Bakhu Holdings's Altman Z2-Score falls into.



Bakhu Holdings Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Bakhu Holdings's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*-3.0798+3.26*-58.9262+6.72*-2.0351+1.05*-0.922
=-226.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Jan. 2024:
Total Assets was $0.83 Mil.
Total Current Assets was $0.43 Mil.
Total Current Liabilities was $2.97 Mil.
Retained Earnings was $-48.73 Mil.
Pre-Tax Income was -0.121 + -1.131 + 2.835 + -3.505 = $-1.92 Mil.
Interest Expense was -0.077 + -0.064 + -0.05 + -0.048 = $-0.24 Mil.
Total Liabilities was $10.61 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(0.426 - 2.973)/0.827
=-3.0798

X2=Retained Earnings/Total Assets
=-48.732/0.827
=-58.9262

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-1.922 - -0.239)/0.827
=-2.0351

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(-9.78 - 0)/10.607
=-0.922

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Bakhu Holdings has a Altman Z2-Score of -226.95 indicating it is in Distress Zones.


Bakhu Holdings  (OTCPK:BKUH) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Bakhu Holdings Altman Z2-Score Related Terms

Thank you for viewing the detailed overview of Bakhu Holdings's Altman Z2-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Bakhu Holdings (Bakhu Holdings) Business Description

Traded in Other Exchanges
N/A
Address
One World Trade Center, Suite 130, Long Beach, CA, USA, 90831
Bakhu Holdings Corp is a development stage company engaged in the production, manufacturing, and sale of cannabis and byproducts. The company also provides cannabis-related research, teaching and education for both medical and other purposes, and all medical uses and applications of cannabis, within the Territory.
Executives
Tom Vaknin director SPYROU KYPRIANOU 16, PYGROS / LIMMASOL G4 4529
Moshe Morgenstern director MENACHEM BEGIN 88, PETAH TIKVAH/CENTRAL DISTRICT L3 49504
Geoffrey Robert Dixon 10 percent owner 16 SHOBY LANE, GRIMSTON X0 LE14 3DD
Michael Richard Hawthorne officer: Deputy CEO 20 LARKSBOROUGH AVENUE, COUNTY DOWN X0 BT23 8SU
Garcia La Sienra Garcia Juan Carlos director, officer: CFO 3 SHANEWOOD CT, THE WOODLANDS TX 77382
Sagi Rami Rozen director HOUSE NUMBER 8, 8 AGIAS TRIADAS STREET (MOUTTAGIAKA), LIMASSOL G4 4527
Cell Science Holding, Ltd. 10 percent owner PANTELI KATELARI 18A, AGIOS IOANNIS, LIMASSOL G4 3012
Mentone, Ltd. 10 percent owner 3 COPLOW CRESCENT, SYSTON, LEICESTER X0 LE7 2JE
Inter-m Traders Fz, Lle 10 percent owner 18A PENTELI KATELARI, LIMASSOL G4 3021
Thomas K Emmitt director, officer: President, CEO and Secretary ONE WORLD TRADE CENTER, SUITE 130, LONG BEACH CA 90831
Aristotle Popolizio director 206 PASSAIC AVENUE, ROSELAND NJ 07068
Evripides Drakos director 139C GLOUCESTER TERRACE, LANCASTER GATE, LONDON X0 W2 6DX
Peter Whitton director 3 COPLOW CRESCENT, SYSTON LEICESTER X0 LE7 2JE
Oz Corp 10 percent owner 24328 VERMONT AVENUE, SUITE 300, HARBOR CITY CA 90710